T
here is a severe shortage of transplantable human organs. One conceptually simple, albeit technically (and ethically) challenging solution would be to grow human organs in animals. But first we must determine whether it is possible to grow a solid organ in a different species and use it to treat disease. Yamaguchi et al. 1 report on page 191 that mouse pancreases can be grown in rat hosts, harvested and parts then transplanted into mice to reverse diabetes.
Adult mammalian organs are intricate in design and, in cellular terms, huge. Billions of cells, often comprising dozens of specialized cell types, must come together as one seamless anatomical and functional unit. Although scientists have begun to master the art of making assemblies of cells that resemble organ precursors in a Petri dish 2 , the microscopic size and rudimentary organization of these organoids is a far cry from that of an adult organ. Making a mature and transplantable organ in vitro, even with the latest advances in stem-cell biology and bioengineering, still seems a distant possibility.
An alternative way to obtain new human organs could be to grow them in a host animal 3 . Scientists have begun to evaluate the radical idea of interspecies organ growth, starting with two closely related laboratory animals, mice and rats. In 2010, the group that performed the current study successfully grew a rat pancreas in a mouse 4 . However, the organ grew to only the size of a mouse pancreas, so was not big enough to be transplanted into the much larger rat and evaluated for functionality.
Yamaguchi et al. now report the opposite experiment, growing a mouse pancreas in a rat host. The researchers accomplished this feat by injecting mouse pluripotent stem cells, which can give rise to every cell type in the body, into rat embryos that were only a few days old. The injected mouse stem cells intermingled with native rat stem cells, and together they proliferated, differentiated and gave rise to rats. Almost every organ and tissue was made up of a mixture of rat and mouse cells. However, the authors suppressed growth of the rat pancreas by genetically engineering the embryos to lack the gene Pdx1 -the master regulator of pancreas development 5 . As such, the main body of the pancreas was made up entirely of mouse cells (Fig. 1) .
Next, the researchers removed the mouse pancreas from the host and from it isolated spherical cell clusters called endocrine islets, which contain the insulin-secreting β-cells. They transplanted the islets into mice that had been rendered diabetic by chemical ablation of their native β-cells. These mice model type 1 diabetes -a particularly severe form of the disease that involves an irreversible loss of β-cells and usually arises in childhood 6 . The transplanted islets survived and were able to replace the native β-cells, secreting insulin and suppressing high blood-sugar levels to return them to within a normal range.
Although most of the cells in the inter species pancreas derive from mouse cells, blood vessels and some supportive cells are of rat origin. One might predict that these cells would trigger prolonged and potentially destructive immune responses after islet transplantation into mice. However, Yamaguchi and colleagues prevented these responses by treating the transplanted mice with a mild immuno suppressant on implantation and for five days thereafter. Moreover, the authors provide evidence that the rat-derived cells disappeared from the transplanted islets over time.
Mouse endocrine islets are relatively small cellular clusters, each containing only a few hundred cells. It is conceivable that, on transplantation, the rat blood vessels inside the islets were recognized by the mouse immune system and rapidly removed, thereby avoiding a prolonged immune response. Perhaps blood vessels from the host mouse extended quickly into these cellular clusters at the same time, re-establishing a blood supply and thus averting tissue destruction. Were an entire organ to be transplanted -the eventual goal for most human therapies -the deeply embedded and extensive vasculature might not be so quickly replaced by the host. This could result in a stronger immune response and substantial organ damage.
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Interspecies pancreas transplants
A mouse pancreas grown in a rat controls blood-sugar levels when transplanted into a mouse that models type 1 diabetes. This achievement provides a tantalizing glimpse of how organs could be grown for therapeutic use. See Article p.191 1 injected mouse pluripotent stem cells into early-stage rat embryos that lacked the gene Pdx1 -a master regulator of pancreas development. These embryos gave rise to rats that contained cell lineages derived from both organisms in all tissues except the pancreas, which was mouse-derived (yellow), apart from blood vessels and some supporting tissues that were of mixed lineage (green). The authors isolated, from the pancreas, cell clusters called endocrine islets that contain insulin-secreting cells, and transplanted them into mice that model type 1 diabetes. The transplanted islets suppressed the high blood-sugar levels associated with diabetes. The rat-derived pancreatic blood vessels disappeared over time, perhaps being replaced by the recipient mouse's own vessels. (Figure adapted We should also expect it to be much more difficult to grow more-complex organs such as the kidney or the heart using this strategy. Unlike the pancreas, these organs arise from several progenitor cell types controlled by separate biological pathways 7, 8 . Suppressing the growth of the entire host kidney or heart is unlikely to be as simple as deleting a few genes, meaning that more-elaborate strategies will probably be required.
Mice and rats are distinct species, but share much of their genetic make-up. Nevertheless, there seem to be as-yet-undefined molecular barriers to rat cell growth or integration into mouse tissues 4 . Would it be possible, then, to use a similar strategy to grow organs in moredistantly related species, in which such problems would presumably be amplified? The eventual aim would be to grow human organs in pigs or sheep, whose organs are of comparable size to those of humans. But major technical challenges probably lie ahead, including poor contribution of human cells to animal embryos and rejection of human organs by the host animal's immune system.
After organ transplants between humans, immunosuppressive drugs must be taken for life to prevent organ rejection. Such drugs are toxic and have serious side effects. But, theoretically, immune-compatible organs could be produced with the interspecies approach using patient-specific induced pluripotent stem (iPS) cells -a type of pluripotent cell generated by taking a patient's skin or blood cells and engineering them to acquire a pluripotent state in vitro. Human endocrine islets derived from iPS cells, for instance, will be immunologically matched with the cell donor. In their experiments, Yamaguchi et al. used mouse iPS cells as well as embryo-derived pluripotent stem cells, demonstrating that both techniques are feasible in rodents.
Before human organs can be grown in animals, many technical challenges will need to be overcome, and ethical and legal questions addressed. But given the pressing clinical need for organs for transplantation, and the lack of good options available, this line of research must continue. ■ Qiao Zhou is in the Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts 02138, USA. e-mail: qiao_zhou@harvard.edu report that most of the increase that occurred in the 2000s can be explained by changes in ocean overturning circulation -the sinking of cold, dense surface waters to the deep ocean, and the compensatory rising of deep waters. This suggests that biological processes and temperature-driven changes in solubility have relatively minor roles.
Ocean carbon uptake is proportional to a quantity known as Δp CO 2 , which is a measure of the difference between the amount of CO 2 in the atmosphere and that in the ocean surface 6 . If there were no changes in ocean temperature, biology or circulation, one would expect ocean carbon uptake to increase in proportion to atmospheric CO 2 levels. Ocean models and estimates based on atmospheric and oceansurface data suggest that ocean CO 2 uptake declined during the 1990s, relative to what might have been expected from atmospheric CO 2 concentrations, and that this decline occurred primarily in the Southern Ocean 3, 4, 7 . This reduction was linked 7, 8 to intensification of the westerly winds over the Southern Ocean, which brought carbon-rich deep waters to the surface and so decreased Δp CO 2 .
Observations of CO 2 levels in the atmosphere and ocean surface suggest that this trend reversed in the early 2000s (refs 4, 9). The Southern Ocean again played a crucial part in this increase in ocean carbon uptake 3, 10 , but uptake also increased at northern mid-latitudes during this period 4 . The post-2000 increase in ocean carbon uptake cannot be explained by a simple reversal of the mechanism that caused the slowdown during the 1990s, because westerly winds continued to strengthen during the 2000s. An analysis of temperature-driven effects on the solubility of CO 2 suggested that these have a substantial role in the uptake of CO 2 in some regions 3, 4 , but cannot explain it entirely. Other processes are needed to fully explain the observed changes 3, 4 . DeVries and colleagues' paper is the first to 5 report that the large-scale circulation of the ocean (the overturning circulation) was weaker during the 2000s than during the 1990s, especially in the upper ocean, and therefore brought less CO 2 -rich water from the ocean depths to the surface. This effect, taken together with increases in anthropogenic CO 2 emissions, increased the CO 2 gradient between the atmosphere and the ocean, driving CO 2 uptake by the ocean. Temperature-driven solubility effects were about tenfold smaller than circulation-driven changes. Because most of the observed change in ocean CO 2 uptake during the 2000s can be explained by changes in circulation and atmospheric CO 2 , it is likely that ocean biology had only a modest role. NEWS & VIEWS RESEARCH
